WHR
55
-2
ZTS
56
-2
BRK.B
42
-3
MCO
80
2
XRX
52
-3
RRC
56
4
DAL
62
-4
HP
41
-4
HBI
62
4
PLD
51
-5
STZ
63
10
MAS
67
-3
R
66
-4
ADI
59
-2
EXC
53
6
NEM
48
2
VLO
40
-5
WU
12
-4
FDX
29
-21
IR
72
-5
WHR
55
-2
ZTS
56
-2
BRK.B
42
-3
MCO
80
2
XRX
52
-3
RRC
56
4
DAL
62
-4
HP
41
-4
HBI
62
4
PLD
51
-5
STZ
63
10
MAS
67
-3
R
66
-4
ADI
59
-2
EXC
53
6
NEM
48
2
VLO
40
-5
WU
12
-4
FDX
29
-21
IR
72
-5
Financhill
Back

Canadian National Railway Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
49

CNR.TO
Canadian National Railway

Last Price:
158.87
Seasonality Move:
3.8%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
49
Canadian National Railway (CNR.TO) is a Sell

Is Canadian National Railway a Buy, Sell or Hold?

  • The current Canadian National Railway [CNR.TO] share price is $158.87. The Score for CNR.TO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CNR.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CNR.TO Stock Price Chart

What is Canadian National Railway's stock price today?

  • The Canadian National Railway share price today is $158.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNR.TO is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CNR.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.76 Buy
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: -470289 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (156.31 - 160.99) Buy
Bollinger Bands (100): (156.92 - 169.98) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CNR.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 160.88 Sell
20-day SMA: 159.5 Sell
50-day SMA: 159.02 Sell
200-day SMA: 167.39 Sell
8-day EMA: 160.28 Sell
20-day EMA: 159.44 Sell
50-day EMA: 159.86 Sell
200-day EMA: 163.48 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Canadian National Railway Earnings Growth & CNR.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.32 per share, an increase this year of $0.35 per share, and an increase next year of $0.98 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Canadian National Railway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):